Ciprofloxacin Hydrochloride/Fluocinolone Acetonide

盐酸环丙沙星/氟轻松丙酮酯

Report date: 2026/05/09 20:00:18

Base Information

Drug NameCiprofloxacin Hydrochloride/Fluocinolone Acetonide
Drug Alias Name盐酸环丙沙星-氟轻松丙酮酯Ciprofloxacin/Fluocinolone盐酸环丙沙星/氟轻松Ciprofloxacin Hydrochloride and Fluocinolone AcetonideCiprofloxacin Hydrochloride●Fluocinolone Acetonide +[19] 
ClassificationSmall molecules > SteroidsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionGlucocorticoid receptor agonistsBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors
TargetsGlucocorticoid receptorBacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsOtitis MediaOtitis Externa
Global Approved IndicationsOtitis MediaOtitis Externa
Approved Indications in ChinaOtitis MediaOtitis Externa
Original Approved Country/TerritoryItaly
Original Approved DateN/A
Country/TerritoryUnited StatesItalyEU +[4] 
CombinationsYes Ciprofloxacin HydrochlorideFluocinolone Acetonide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLaboratorios Salvat Sa
China Registration ClassN/A

Develop Information

Active CompaniesLee’S Pharmaceutical Holdings LtdLaboratorios Salvat SaOnconetix Inc
Inactive CompaniesZhaoke Pharmaceutical (Hefei) Co Ltd
Active IndicationsOtitis MediaOtitis Externa
Inactive IndicationsN/A

Other Information

ATC CodeS01CA10S02CA05
Related LinksN/A